Molecular Insight Pharmaceuticals, Inc. to Present at Rodman and Renshaw 11th Annual Healthcare Conference
Sep 4, 2009 - 9:36:01 AM
News Source MARKET WIRE
|
Email this article
Printer friendly page
|
CAMBRIDGE, MA -- (Marketwire) -- 09/04/09 -- Molecular InsightPharmaceuticals, Inc. (NASDAQ: MIPI) will make a presentation at theRodman and Renshaw 11th Annual Healthcare Conference on September 10, 2009at 2 PM, Eastern Daylight Time. Daniel L. Peters, President and ChiefExecutive Officer, will present an overview of the Company and its pipelineof targeted therapeutic and molecular imaging radiopharmaceuticals. Thepresentation will take place in the Fahnestock Salon, on the fifth floor ofthe New York Palace Hotel in New York, New York.The presentation will be webcast live athttp://www.wsw.com/webcast/rrshq15/mipi and will be archived for 90 days.The webcast also will be available in the Investor Relations section of theMolecular Insight Pharmaceuticals website at www.molecularinsight.com. About Molecular Insight Pharmaceuticals, Inc. Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceuticalcompany and a pioneer in the emerging field of molecular medicine. TheCompany is focused on the discovery and development of therapeuticradiopharmaceuticals and targeted molecular imaging in oncology andcardiology. Molecular Insight has five clinical-stage candidates indevelopment. The Company's oncology candidates include: Azedra(TM) fortreatment of pheochromocytoma and neuroblastoma, Onalta(TM) forthe treatment of metastatic carcinoid and pancreaticneuroendocrine tumors, Solazed(TM), which targets malignant metastaticmelanoma, and Trofex for the detection of metastatic prostate cancer. Zemiva(TM) isbeing developed for the diagnosis of acute myocardial ischemia. For furtherinformation on Molecular Insight Pharmaceuticals, please visitwww.molecularinsight.com. Contact:
Investors
Deborah S. Lorenz
Senior Director
Investor Relations and Corporate Communications
(617) 871-6667
dlorenz@molecularinsight.com
Media
Martin A. Reynolds
Manager
Corporate Communications
(617) 871-6734
mreynolds@molecularinsight.com
Top of Page |
Main News Index |
EmpireRelations.com Home Page
EmpireRelations.com Selected Clients News
Copr. © 2005 Empire Relations Group, Inc.
|
